josh farkas 💊
banner
pulmcrit.bsky.social
josh farkas 💊
@pulmcrit.bsky.social
Pulm/crit attending at U. Vermont 🐄 Zentensivist 🧘‍♂️ trying to post more about medicine in order to distract myself from doomscrolling 🤦‍♂️ author of free online critical care textbook emcrit.org/ibcc/toc/ 📖 no conflicts of interest 💰
Trimethoprim-sulfamethoxazole carries a very low (but real) risk of causing ARDS.

Duration of therapy is a risk factor (>7 days).

Could likely be minimized by avoiding unnecessarily long courses.

TMP-SMX is usually well tolerated, but can wreak havok (SJS, ARDS, drug-induced meningitis). #EMIMCC
November 24, 2025 at 8:48 PM
New study design:

Multiply a small & uncertain number with a big number and you get a big number

The final big number looks, well, really big

This grabs headlines & gets cited

It doesn’t clarify underlying uncertainty, so it doesn’t actually illuminate anything

Mathematically rigorous clickbait
November 23, 2025 at 2:27 PM
I’d propose a formal framework for reaching a “probable HRS-AKI” diagnosis.

A probable HRS-AKI dx could be reached without delay (based on H&P, chart review, and POCUS evaluation of heart & kidney)

This would allow immediate treatment in parallel with ongoing investigation.

#EMIMCC
November 23, 2025 at 2:02 PM
In terms of osm, you dont need to worry about what the cations are doing because the anions will balance them out

I think if you did the math the actual amount of H+ liberated would be minimal.
November 23, 2025 at 2:24 AM
a fancy nephrology guideline trying to describe how to titrate a norepi gtt is sending me 🤣

adjust q4hr??

the whole point of a NE gtt in HRS-AKI is immediate BP control

tell the ICU RN the target MAP and they will achieve it immediately... that's why NE gtts are great

(and peripheral IV is fine)
November 22, 2025 at 8:57 PM
Roon is launching a social media site for USA doctors only

Looks lame

The strength of MedTwitter has always been diversity (geographic & training - docs, RNs, PAs, pharmacists etc)

Further fractionating our community isn't the way forward

I think Bluesky is ideal; we just need more people here
November 19, 2025 at 4:46 PM
Finished updating the IBCC chapter on septic shock

This algorithm is where I ended up 👇

Therapies should be based on several factors (not solely whether CRT is <3; CRT isn't precise so this dichotomy is problematic)

Beware of vasopressin; it may depress digital perfusion & block the goal #EMIMCC
November 19, 2025 at 2:01 PM
Single-center RCT finds benefit from sepsis resus that targets perfusion index (Pi)

Intervention group: fix macrohemodynamics, then target Pi >1.4

I think they're right

Pi is similar to cap refill, but continuously displayed number on monitor 😍

pubmed.ncbi.nlm.nih.gov/41033063/ #EMIMCC
November 18, 2025 at 3:15 PM
there's been LOTS of back-and-forth about vaso in sepsis

(e.g., these two 2025 review articles reach totally different conclusions! Lajoye is correct IMHO)

TLDR: there is no simple answer; personalize tx 🌌

my current take on vaso in sepsis is here: emcrit.org/ibcc/shock/#... #EMIMCC
November 13, 2025 at 6:52 PM
Fresh IBCC: POCIT (Point-of-care infrared thermography)

This is basically where POCUS was 1995-2005

Technology & evidence-basis are improving

Early adopters may be interested

IMHO anything bringing us to the bedside more & forcing us to engage w/ the exam is good

emcrit.org/ibcc/pocit/ #EMIMCC
November 13, 2025 at 2:00 PM
I'm revising the IBCC septic shock chapter based on ANDROMEDA-SHOCK II

would love any feedback & critique on this

ANDROMEDA algorithm is nice, but it's too complicated for everyday use. We need something simpler.

& maybe it's time to push for IR thermography 😍

emcrit.org/ibcc/sepsis/... #EMIMCC
November 10, 2025 at 1:16 PM
our therapy dog posing as a lion wins halloween, thanks for playing everyone
October 31, 2025 at 4:31 PM
this same post was posted on twitter and got no engagement there either.
October 30, 2025 at 11:32 PM
updated the IBCC section on alcoholic hepatitis.

AGA 2024 guidelines seem sensible & useful (picture below)

Key points:

🍺Steroid recommended for MELD>20

🍺Aggressive multiorgan support PRN (may have hepatorenal syndrome, sepsis, etc)

🍺Consider acetylcysteine

emcrit.org/ibcc/aclf/#a... #EMIMCC
October 30, 2025 at 7:56 PM
The way this NEJM study on prostate CA was framed & is being publicised is misleading

13% relative reduction in prostate CA-related mortality is PITIFUL (for comparison, colonoscopy causes ~60% relative reduction)

There's obviously no dent in all-cause mortality (maybe higher with screening) #1/2
October 30, 2025 at 2:49 PM
Great & important trial that demonstrates safety & efficacy of capillary refill time to guide resus

But it's a stretch to claim this shows *superiority*

If you need a risk-stratified win ratio to demonstrate superiority at a p=0.04 level, the intervention probably isn't terribly effective #EMIMCC
October 29, 2025 at 4:29 PM
MASSIVE RCT from Kenya showing that steroids reduce mortality in CAP

Mortality benefit easier to demonstrate w/ less resources available to salvage pts

Should allay the hype that the negative REMAP-CAP steroid RCT received (despite being woefully underpowered)

www.nejm.org/doi/pdf/10.1... #EMIMCC
October 29, 2025 at 3:37 PM
New RCT: Avoiding A-line in shock didn't affect mortality (trend towards *reduction*) & decreased line complications

They avoided A-lines despite patients requiring pretty substantial doses of vasopressors

Very #zentensivist

Don't need to rush to an A-line

www.nejm.org/doi/full/10.... #EMIMCC
October 29, 2025 at 3:19 PM
The BICAR-ICU-2 trial just dropped!

RCT involving IV bicarb in metabolic acidosis among patients with mod-severe AKI

Bicarb didn't affect mortality but it reduced the need for dialysis & risk of bacteremia

VERY similar conclusions to BICAR-ICU-1

🧵 #1/

jamanetwork.com/journals/jam... #EMIMCC
October 29, 2025 at 2:59 PM
I continue to be shocked by how PCN allergies are misunderstood

This is from UpToDate on neutropenic fever

It's wrong

With PCN allergy, you can absolutely use cefepime, piptazo, or meropenem

The R-chain structure that determines allergy is different

emcrit.org/ibcc/penicil... #EMIMCC #IDsky
October 28, 2025 at 8:55 PM
The entire IDSA guideline on diabetic foot infection doesn't include the word "cefepime." Not once.

It does recommend piperacillin-tazobactam in certain cases.

I'm not saying you *can't* use cefepime (you absolutely can and should in some cases), but such therapy isn't guideline-directed. 🤷‍♂️
October 27, 2025 at 3:22 PM
New blog: Fresh dueling guidelines about post-arrest care from the AHA and ESICM

💔 BP targets
💔 Who needs an emergent cath?
💔 O2 targets
💔 pan-CT scans
💔 temp targets
💔 neuroprognostication

Which guideline do I love? 😍 You'll have to read the post to find out.

emcrit.org/pulmcrit/202... #EMIMCC
October 26, 2025 at 2:51 PM
We’ve known for a while that drowning pancreatitis patients is bad

the WATERFALL RCT recently showed benefit from a more conservative fluid strategy

the authors used the study protocol to create a concrete fluid protocol which is very good

so we have a good, evidence-based fluid protocol 😃 #2/6
October 24, 2025 at 1:28 PM
this is from a 2000-word review article with a dozen authors on a purely gastroenterology topic.

I've been noticing this pattern more and more: a large & bizarre collection of authors that doesn't make organic sense.

Does anyone understand exactly what is going on here? Some sort of article mill?
October 11, 2025 at 2:07 PM
The difference between an expert vs amateur DKA resus is really efficiency

Patients are overwhelmingly likely to do well regardless

Expert resus may accelerate resolution & avoid re-opening the gap

So there are other hills to die on

If your protocols work efficiently, there’s no reason to change
October 5, 2025 at 11:56 AM